1 – 11 of 11
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study
(
- Contribution to journal › Published meeting abstract
- 2019
-
Mark
Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
(
- Contribution to journal › Article
- 2018
-
Mark
Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration
(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
(
- Contribution to journal › Article
-
Mark
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread : A case control study
(
- Contribution to journal › Article
- 2016
-
Mark
Changes in expression of genes representing key biologic processes after neoadjuvant chemotherapy in breast cancer, and prognostic implications in residual disease
(
- Contribution to journal › Article
-
Mark
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
2016) In Nature Genetics(
- Contribution to journal › Article
- 2015
-
Mark
An international study to increase concordance in Ki67 scoring.
(
- Contribution to journal › Article
- 2014
-
Mark
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
(
- Contribution to journal › Article
- 2012
-
Mark
Effects of cyclin D-1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
(
- Contribution to journal › Article